Media Release | March 19, 2015
Scientists at the University of British Columbia and Janssen Research & Development LLC have shown for the first time that Type 2 diabetes can be effectively treated with a combination of specially-cultured stem cells and conventional diabetes drugs.
Media Release | September 11, 2014
UBC, in collaboration with BetaLogics Venture, a division of Janssen Research & Development, LLC, has published a study highlighting a protocol to convert stem cells into insulin-producing cells.
December 18, 2012 - by Tim Kieffer, Head, Diabetes Research Group
The discovery of new sources of stem cells may herald the end of insulin injections.